|
|
Lawrence W Adler
M.D.
|
| Academic Title:
Clinical Assistant Professor |
| Primary Appointment:
Psychiatry |
|
adler@clinicalinsights.com |
| Location:
701 W. Pratt St.,
388 |
| Phone:
(410) 768-2698 |
| Phone:
(443) 621-6733 |
| Fax:
(410) 761-7984 |
|
Personal History
Education
B.S., 9/67-6/71, University of Maryland, College Park, Biochemistry
M.D., 9/71-12/75, University of Maryland School of Medicine
Certificate of Graduate Studies, 2007, Business of Medicine, Carey Business School, Johns Hopkins University
Post Graduate Education and Training
Post-doctoral Research Associate, 12/75-7/76, University of Maryland School of Medicine, Dept. of Biological Chemistry
Residency in Psychiatry, 7/76-6/79, Sheppard-Pratt Hospital
Certifications
Psychiatry, American Board of Psychiatry and Neurology, 1983, #25039
Geriatric Psychiatry, American Board of Psychiatry and Neurology, April 1991-December 2001, December 2001-December 2011, #004
Clinical Psychopharmacology, American Society of Clinical Psychopharmacology,November 1998-May 2009
Certified Physician Investigator, Association of Pharmaceutical Physicians and Investigators, November 2002-ongoing
Research Interests
* Clinical psychopharmacology
* Clinical research
* Public Health
* Epidemiology and genetics of psychiatric illness
Clinical Speciality
* Clinical psyschopharmacology
* Geriatric psychiatry
Publications
Peer-Reviewed Journals
Klein, D.F.#, Thase, M.E., Endicott, J., Adler, L., Glick, I., Kalali, A., Leventer, S., Mattes, J., Ross, P., Bystristsky, A. Improving Clinical Trials: American Society of Clinical Psychopharmacology Recommendations. Archives of General Psychiatry, 2002 March; 59(3): 272-8.
Hertzman, M, Adler, L.W.# , Arlen, B, Kern, M. Lisinopril May Augment Antidepressant Response. Journal of Clinical Psychopharmacology, 25(2005) 618-620
Keefe RSE.#, Bilder RM, Harvey, PD, Davis, SM, Palmer, BW, Gold, JM, Meltzer, HY, Green, MF, Miller, DD, Canive, JM, Adler, LW, Mansschreck, TC, Swartz, M, Rosenheck, R, Perkins, DO, Walker, TM, Stroup TS, McEvoy, JP, Lieberman, JA. Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial. Neuropsychopharmacology, advanced online publication 19 April 2006, 1-14
Presentations
Adler, L.W. Alzheimer's Disease Prevention: Is Lithium Neuroprotective? Paper presented at American Association of Geriatric Psychiatry Annual Meeting, San Diego, CA, 2005.
Adler, LW.#, Zepp, H, Cerro, L. A Model for Integrating Clinical Trials in a Community Practice Setting. Presented at APA Institute for Psychiatric Services, San Diego, CA, 2005
Adler, L.W. Alzheimer's Disease: A Final Common Pathway for Genetic Risk, Vascular Risk, Mood Dysregulation and Energy Dysregulation. Presented at American Association of Geriatric Psychiatry Annual Meeting, Puerto Rico, 2006
Adler, L.W.#, Cerro L,and Zepp H. A Meta-Analysis of the Efficacy of Paroxetine vs. Placebo Utilizing the GlaxoSmithKline Clinical Trials Registry. Presented at APA Annual Meeting, Toronto,CA, 2006
Adler, L.W.#, Remission of Major Depressive Episodes on Paroxetine vs. Placebo in Elderly and Adult Subjects. Presented at American Association of Geriatric Psychiatry Annual Meeting, New Orleans, LA, 2007
Adler, L.W.#, Reducing the Medical and Financial Burden of Depressive Illness: A Plan for Improving Health Care Services. Presented at the American Psychiatric Association Annual Meeting, San Diego, CA, 2007
Faculty members:
Click here to update your contact information and create a profile.
|